Daniel J Haraf MD
Professor and medical director, Radiation Oncology University of Chicago
Join to View Full Profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Fax+1 773-702-0610
Dr. Haraf is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Haraf is a radiation oncologist based in Chicago, IL, with specialized experience in lung cancer, prostate cancer, neck pain, head, and neck neoplasms, as well as combined modality therapy. He completed his medical education at Chicago Medical School at Rosalind Franklin University of Medicine and Science, followed by residencies in internal medicine at Michael Reese Hospital and Medical Center and radiation oncology at the University of Chicago/University of Illinois College of Medicine. His work includes significant publications in renowned journals such as Clinical Cancer Research and JAMA Oncology, focusing on treatment strategies for oropharyngeal and head and neck cancers. He has been involved in clinical trials like the PROGRESS Trial, and his contributions have earned him recognitions such as America's Top Doctors and Chicago Magazine's Top Doctors. Additionally, he has received certifications from Epic Systems Corporation for meaningful use in electronic health records.
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 1985 - 1988
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982
Certifications & Licensure
IL State Medical License 1983 - 2029
American Board of Internal Medicine Internal Medicine
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
Clinical Trials
- PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing Start of enrollment: 2018 Jan 22
Publications & Presentations
PubMed
- 3 citationsEarly Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer.Ari J Rosenberg, Evgeny Izumchenko, Aditya Juloori, Rohan Katipally, John Cursio
Clinical Cancer Research. 2025-08-01 - 23 citationsNeoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized C...Ari J Rosenberg, Aditya Juloori, Michael J Jelinek, Nishant Agrawal, John F Cursio
JAMA Oncology. 2025-05-01 - 36 citationsNeoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Controlled Trial.Ari J Rosenberg, Nishant Agrawal, Aditya Juloori, John Cursio, Zhen Gooi
JAMA Oncology. 2024-07-01
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Other
- Paranasal sinus cancerHaraf DJ, Stenson KM
http://www.uptodate.com/contents/paranasal-sinus-cancer
UpToDate, Wolters Kluwer Health - 2012-04-06 - Reirradiation for locally recurrent head and neck cancerHaraf DJ, Salama JK, Milano MT
http://www.uptodate.com/contents/reirradiation-for-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-07-20 - Treatment of locally recurrent head and neck cancerHaraf DJ, Milano MT, Chmura SJ
http://www.uptodate.com/contents/treatment-of-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-08-29
Press Mentions
First He Survived Cancer – Now He Studies ItNovember 14th, 2022
Grant Support
- Core--Biostatistics, Data Management And ClinicalNational Institute Of Dental &Craniofacial Research1996–2001
- Core--Clinical Trial Protocol Review And Monitoring SystemNational Cancer Institute1996–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
